Full-Time

Lab Operations Associate

Full Time

Confirmed live in the last 24 hours

Tr1X

Tr1X

11-50 employees

Develops cellular immunotherapies for autoimmune diseases

Biotechnology
Healthcare

Compensation Overview

$65k - $85kAnnually

Entry, Junior

No H1B Sponsorship

San Diego, CA, USA

Category
Lab & Research
Life Sciences
Required Skills
Inventory Management
Requirements
  • A BS with 2+ years of previous industry experience in related role
  • The ability to interface and communicate well across all levels of an organization as well as with outside vendors.
  • Good relationship building and problem-solving skills.
  • Ability to perform in a start-up environment.
  • Working general knowledge of common equipment used in immunology and cell biology laboratories such as plate readers, MSD, Luminex, flow cytometry, laminar flow hoods, etc.
  • Knowledge of laboratory safety policies (i.e., chemical, biological, BSL2+)
  • Legally entitled to work for any employer in the US.
  • Able to work five days a week in an office/lab setting.
Responsibilities
  • Assist – with all aspects of laboratory operations including laboratory services and support, procurement, equipment management, waste management, material management, inventory and logistics.
  • Support – general laboratory and facility-related work requests and the ordering, receiving, and stocking of laboratory supplies and reagents.
  • Maintain – inventory of supplies, maintenance plans and logs, and use instructions for all equipment.
  • Ensure – cleanliness and overall organization of all areas of the laboratory and that general use laboratory items are in adequate supply such as dry ice, LN2, CO2, laboratory coats, etc.
  • Take - responsibility to maintain laboratory records, reports and files.
  • Manage - and resolve administrative and technical problems.
  • Recommend - and assist in the implementation of goals and objectives; implement approved policies and procedures.

Tr1X focuses on developing cellular immunotherapies aimed at treating autoimmune and inflammatory diseases. The company uses a proprietary platform to create cell therapy products that help to rebalance the immune system and restore balance within the body, which can lead to long-term tolerance of the immune response. Unlike many other companies in the biopharmaceutical sector, Tr1X specializes in first-in-class therapies that target the underlying causes of immune system disorders. The goal of Tr1X is to provide advanced therapeutic solutions that improve the quality of life for patients suffering from these challenging conditions.

Company Stage

Series A

Total Funding

$73M

Headquarters

San Diego, California

Founded

2018

Growth & Insights
Headcount

6 month growth

9%

1 year growth

36%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • The $75M Series A financing led by prominent investors like The Column Group and NEVA SGR provides strong financial backing for rapid development and execution.
  • Initiating Phase 1 studies for GvHD and planning an IND for Crohn's disease in 2024 positions Tr1X for significant clinical milestones and potential market entry.
  • The off-the-shelf nature of TRX103 offers a cost-effective and scalable solution, potentially revolutionizing treatment paradigms for autoimmune and inflammatory diseases.

What critics are saying

  • The success of Tr1X heavily depends on the clinical outcomes of its Phase 1 studies, which are inherently uncertain.
  • The competitive landscape in cell therapy is intense, with numerous companies vying for FDA approvals and market share.

What makes Tr1X unique

  • Tr1X focuses on developing allogeneic regulatory T cell therapies (Allo-Tregs) and CAR-Treg cell therapies, setting it apart from competitors who may focus on autologous or other cell therapy approaches.
  • The company's highly scalable platform allows for efficient pipeline expansion, providing a competitive edge in rapidly addressing multiple autoimmune and inflammatory diseases.
  • FDA clearance for TRX103, the first ever allogeneic engineered Tr1 regulatory T cell product, underscores Tr1X's pioneering role in the cell therapy landscape.

Help us improve and share your feedback! Did you find this helpful?